As nucleolin controls rRNA synthesis/ribosome biogenesis, and this process is also controlled by mTOR–P70S6K signaling, we hypothesized that MeCP2 mutations in human RTT brain would be associated with deregulation of nucleolin, rRNA transcripts, and mTOR–P70S6K signaling. The gene discussed is RPS6KB1; the disease is Rett syndrome.